savolitinib,sunitinib,cabozantinib,crizotinib,nivolumab,ipilimumab,Bicalutamide,Goserelin acetate,Leuprolide acetate,Avelumab,Axitinib,pembrolizumab,Lenvatinib
astrazeneca,bms,pfizer,exelixis,hutchmed,tolmar,sanofi,recordati,merck,eisai
['pdigree', 'rcc,(-irccs),(-srcc),(-urcc)', 'papmet', 'renal,(-adrenal)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'probe']
great start to final day of #gu23 meeting to discuss nctn renal trials pdigree, radical, samurai, probe and papmet2 - the future of rcc 
Assistant Professor Harvard Medical School; Director of Clinical Research, Lank Center for GU Oncology DFCI COI -coi.asco.org/share/EXE-GEFM…